BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20797689)

  • 41.
    Alonso-Gonzalez A; Rodriguez-Fontenla C; Carracedo A
    Front Genet; 2018; 9():406. PubMed ID: 30298087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Damaging coding variants within kainate receptor channel genes are enriched in individuals with schizophrenia, autism and intellectual disabilities.
    Koromina M; Flitton M; Blockley A; Mellor IR; Knight HM
    Sci Rep; 2019 Dec; 9(1):19215. PubMed ID: 31844109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders.
    Li J; Wang L; Guo H; Shi L; Zhang K; Tang M; Hu S; Dong S; Liu Y; Wang T; Yu P; He X; Hu Z; Zhao J; Liu C; Sun ZS; Xia K
    Mol Psychiatry; 2017 Sep; 22(9):1282-1290. PubMed ID: 28831199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.
    Yu Y; Lin Y; Takasaki Y; Wang C; Kimura H; Xing J; Ishizuka K; Toyama M; Kushima I; Mori D; Arioka Y; Uno Y; Shiino T; Nakamura Y; Okada T; Morikawa M; Ikeda M; Iwata N; Okahisa Y; Takaki M; Sakamoto S; Someya T; Egawa J; Usami M; Kodaira M; Yoshimi A; Oya-Ito T; Aleksic B; Ohno K; Ozaki N
    Transl Psychiatry; 2018 Jan; 8(1):12. PubMed ID: 29317596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postzygotic single-nucleotide mosaicisms contribute to the etiology of autism spectrum disorder and autistic traits and the origin of mutations.
    Dou Y; Yang X; Li Z; Wang S; Zhang Z; Ye AY; Yan L; Yang C; Wu Q; Li J; Zhao B; Huang AY; Wei L
    Hum Mutat; 2017 Aug; 38(8):1002-1013. PubMed ID: 28503910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population.
    Kessler MD; Loesch DP; Perry JA; Heard-Costa NL; Taliun D; Cade BE; Wang H; Daya M; Ziniti J; Datta S; Celedón JC; Soto-Quiros ME; Avila L; Weiss ST; Barnes K; Redline SS; Vasan RS; Johnson AD; Mathias RA; Hernandez R; Wilson JG; Nickerson DA; Abecasis G; Browning SR; Zöllner S; O'Connell JR; Mitchell BD; ; ; O'Connor TD
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2560-2569. PubMed ID: 31964835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of
    Furuta S; Aleksic B; Nawa Y; Kimura H; Kushima I; Ishizuka K; Kato H; Toyama M; Arioka Y; Mori D; Morikawa M; Inada T; Ozaki N
    Nagoya J Med Sci; 2022 May; 84(2):260-268. PubMed ID: 35967956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism.
    Kumar RA; Sudi J; Babatz TD; Brune CW; Oswald D; Yen M; Nowak NJ; Cook EH; Christian SL; Dobyns WB
    J Med Genet; 2010 Feb; 47(2):81-90. PubMed ID: 19546099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights Into
    Pranckėnienė L; Jakaitienė A; Ambrozaitytė L; Kavaliauskienė I; Kučinskas V
    Front Genet; 2018; 9():315. PubMed ID: 30154829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Statistical Framework for Mapping Risk Genes from De Novo Mutations in Whole-Genome-Sequencing Studies.
    Liu Y; Liang Y; Cicek AE; Li Z; Li J; Muhle RA; Krenzer M; Mei Y; Wang Y; Knoblauch N; Morrison J; Zhao S; Jiang Y; Geller E; Ionita-Laza I; Wu J; Xia K; Noonan JP; Sun ZS; He X
    Am J Hum Genet; 2018 Jun; 102(6):1031-1047. PubMed ID: 29754769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Machine learning analysis of exome trios to contrast the genomic architecture of autism and schizophrenia.
    Sardaar S; Qi B; Dionne-Laporte A; Rouleau GA; Rabbany R; Trakadis YJ
    BMC Psychiatry; 2020 Feb; 20(1):92. PubMed ID: 32111185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss-of-function de novo mutations play an important role in severe human neural tube defects.
    Lemay P; Guyot MC; Tremblay É; Dionne-Laporte A; Spiegelman D; Henrion É; Diallo O; De Marco P; Merello E; Massicotte C; Désilets V; Michaud JL; Rouleau GA; Capra V; Kibar Z
    J Med Genet; 2015 Jul; 52(7):493-7. PubMed ID: 25805808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rare variants and the oligogenic architecture of autism.
    Wang T; Zhao PA; Eichler EE
    Trends Genet; 2022 Sep; 38(9):895-903. PubMed ID: 35410794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and architecture of de novo mutations in developmental disorders.
    Deciphering Developmental Disorders Study
    Nature; 2017 Feb; 542(7642):433-438. PubMed ID: 28135719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease.
    Ku CS; Tan EK; Cooper DN
    J Med Genet; 2013 Apr; 50(4):203-11. PubMed ID: 23396985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder?
    Kinney DK; Barch DH; Chayka B; Napoleon S; Munir KM
    Med Hypotheses; 2010 Jan; 74(1):102-6. PubMed ID: 19699591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variation in genome-wide mutation rates within and between human families.
    Conrad DF; Keebler JE; DePristo MA; Lindsay SJ; Zhang Y; Casals F; Idaghdour Y; Hartl CL; Torroja C; Garimella KV; Zilversmit M; Cartwright R; Rouleau GA; Daly M; Stone EA; Hurles ME; Awadalla P;
    Nat Genet; 2011 Jun; 43(7):712-4. PubMed ID: 21666693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
    Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
    Mol Autism; 2017; 8():14. PubMed ID: 28344757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level.
    Daoud H; Bonnet-Brilhault F; Védrine S; Demattéi MV; Vourc'h P; Bayou N; Andres CR; Barthélémy C; Laumonnier F; Briault S
    Biol Psychiatry; 2009 Nov; 66(10):906-10. PubMed ID: 19545860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.